Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Alembic Pharmaceuticals Limited (NSE: APLLTD), ISIN INE901L01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
APLLTD last traded at ₹844.40 (+0.51%), with a 52-week range of ₹635.30 to ₹998.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 69.87%, FIIs 4.18%, DIIs 15.94%, mutual funds 8.73%.
EquiSense Score (ECS): 76/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.